| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698351 | Clinical Oncology | 2015 | 10 Pages |
Abstract
Data from the ARIES study suggest that treatment with bevacizumab in combination with chemotherapy is a viable first-line treatment option for elderly bevacizumab-eligible patients with advanced non-squamous NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.J. Wozniak, M.P. Kosty, M. Jahanzeb, J.R. Brahmer, D.R. Spigel, L. Leon, S. Fish, E.D. Flick, S.J. Hazard, T.J. Jr.,